Tag: Drug Controller General of India

Lupin, Enzene Biosciences to launch cancer drug Cetuximab biosimilar in India

businessnewstoday- May 31, 2023

Lupin, an Indian pharmaceutical company, has announced a strategic collaboration with Enzene Biosciences, a subsidiary of Alkem Laboratories, to introduce Cetuximab in India. Cetuximab is ... Read More

Themis Medicare gets DGCI approval for narcotic painkiller REMITHEM

businessnewstoday- February 17, 2023

Themis Medicare has been granted approval from the Drug Controller General of India (DCGI) for importing and commercialization of Remifentanil 1 mg/2mg Powder for Concentrate ... Read More

Zydus Cadila gets EUA for ZyCoV-D vaccine for Covid-19 in India

pallavi123- August 20, 2021

Zydus Cadila (Cadila Healthcare) said that it has secured the emergency use authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D vaccine ... Read More

India clears Zydus Cadila’s Virafin for treatment of moderate Covid-19

pallavi123- April 24, 2021

Zydus Cadila has secured restricted emergency use approval for ‘Virafin’, Pegylated Interferon alpha-2b (PegIFN) from the Drug Controller General of India (DCGI) for the treatment ... Read More

Russia’s RDIF gets Indian approval for Sputnik V Covid-19 vaccine

pallavi123- April 13, 2021

The Russian Direct Investment Fund (RDIF) has announced that the Sputnik V Covid-19 vaccine has been approved for use in India by the Drug Controller ... Read More

Dr. Reddy’s secures EUA for Sputnik V vaccine in India for Covid-19 prevention

pallavi123- April 13, 2021

Dr. Reddy’s Laboratories has secured permission from the Drug Controller General of India (DCGI) for importing the Sputnik V vaccine into India under emergency use ... Read More

Glenmark Pharmaceuticals launches FabiFlu for COVID-19 treatment in India

pharmanewsdaily- June 21, 2020

Glenmark Pharmaceuticals has secured approval from India to launch Japan-based Fujifilm's antiviral drug favipiravir under the brand name FabiFlu for the treatment of COVID-19 in ... Read More